Last reviewed · How we verify

[18F]JNJ-64511070

Janssen Research & Development, LLC · Phase 1 active Small molecule

At a glance

Generic name[18F]JNJ-64511070
SponsorJanssen Research & Development, LLC
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.